NIP
VIVS

Nicholas Investment Partners’s VivoSim Labs VIVS Stock Holding History

Nicholas Investment Partners’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-176
Closed -$468K – 330
2013
Q4 		$468K Buy
+176
New +$345K 0.04% 294

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nicholas Investment Partners's VIVS Position: Q1 2014 in Review

Nicholas Investment Partners sold out of VivoSim Labs (VIVS) in Q1 2014, closing a stake of 176 shares — an estimated $468K sold.

Nicholas Investment Partners first reported a position in VIVS in Q4 2013 and held it in 1 quarter. The position peaked at $468K in Q4 2013. 94 funds tracked by Wall St. Rank hold VIVS as of Q1 2014.

  • Nicholas Investment Partners reported no remaining VivoSim Labs position as of Q1 2014 after selling out during the quarter.
  • Nicholas Investment Partners sold 176 VivoSim Labs shares in Q1 2014, an estimated $468K.
  • Nicholas Investment Partners first reported a position in VivoSim Labs in Q4 2013 and held it in 1 quarter.
  • Nicholas Investment Partners's VivoSim Labs position peaked at $468K in Q4 2013.
  • 94 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2014.

Based on Nicholas Investment Partners's 13F filing for Q1 2014, filed 8 May 2014.